Your search has returned 332 record(s).
Click on the thumbnails to view image details.
Download Image |
Thumbnail |
Histogram |
Interpretation |
 |
 |
 |
NILM: Endocervical cells |
 |
 |
 |
NILM: Squamous metaplasia |
 |
 |
 |
NILM: Bacteria morphologically consistent with Actinomyces spp. |
 |
 |
 |
NILM: Cellular changes consistent with Herpes simplex virus |
 |
 |
 |
NILM: Reactive squamous cells |
 |
 |
 |
NILM: Reactive squamous cellular changes associated with Trichomonas vaginalis |
 |
 |
 |
NILM: Squamous metaplasia |
 |
 |
 |
NILM: Endocervical cells: reparative |
 |
 |
 |
NILM: Reactive cellular changes, Repair |
 |
 |
 |
NILM: Repair |
 |
 |
 |
NILM: Reactive squamous cell |
 |
 |
 |
NILM: Atrophy with inflammation (atrophic vaginitis) |
 |
 |
 |
NILM: Atrophy |
 |
 |
 |
NILM: Atrophy |
 |
 |
 |
NILM: Atrophy with inflammation (atrophic vaginitis) |
 |
 |
 |
NILM: Tubal metaplasia |
 |
 |
 |
NILM: Keratotic cellular changes?"typical parakeratosis" |
 |
 |
 |
NILM: Keratotic cellular changes:"typical parakeratosis" |
 |
 |
 |
NILM: Keratotic cellular changes-Hyperkeratosis |
 |
 |
 |
NILM: menstrual smear |
 |
 |
 |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended |
 |
 |
 |
NILM |
 |
 |
 |
NILM vs ASC-US |
 |
 |
 |
ASC-US |
 |
 |
 |
ASC-US (Low end) |
 |
 |
 |
ASC-US |
 |
 |
 |
ASC-US |
 |
 |
 |
ASC-H |
 |
 |
 |
NILM vs ASC-H |
 |
 |
 |
ASC-H |
 |
 |
 |
ASC-H versus HSIL |
 |
 |
 |
ASC-H |
 |
 |
 |
ASC-H |
 |
 |
 |
ASC-H |
 |
 |
 |
ASC-H |
 |
 |
 |
NILM: Histiocytes |
 |
 |
 |
LSIL |
 |
 |
 |
LSIL |
 |
 |
 |
LSIL |
 |
 |
 |
LSIL |
 |
 |
 |
LSIL |
 |
 |
 |
NILM |
 |
 |
 |
LSIL |
 |
 |
 |
ASC-US vs LSIL |
 |
 |
 |
ASC-US vs LSIL |
 |
 |
 |
ASC-US vs LSIL (Borderline) |
 |
 |
 |
HSIL |
 |
 |
 |
HSIL |
 |
 |
 |
HSIL |
 |
 |
 |
HSIL |
 |
 |
 |
SIL |
 |
 |
 |
HSIL |
 |
 |
 |
HSIL |
 |
 |
 |
LSIL/HSIL (Borderline) |
 |
 |
 |
HSIL, r/o invasion |
 |
 |
 |
HSIL in Mucus Strand |
 |
 |
 |
NILM: Microglandular hyperplasia |
 |
 |
 |
Squamous cell carcinoma |
 |
 |
 |
Squamous cell carcinoma |
 |
 |
 |
Squamous Cell Carcinoma-clinging diathesis |
 |
 |
 |
Atypical endocervical cells, NOS |
 |
 |
 |
Atypical endocervical cells, NOS, HSIL |
 |
 |
 |
Atypical endometrial cells |
 |
 |
 |
Atypical endometrial cells |
 |
 |
 |
Atypical endometrial cells |
 |
 |
 |
Endocervical adenocarcinoma in situ (AIS) |
 |
 |
 |
Endocervical adenocarcinoma in situ (AIS) |
 |
 |
 |
Endocervical adenocarcinoma in situ (AIS) |
 |
 |
 |
Endocervical adenocarcinoma in situ (AIS) |
 |
 |
 |
Adenocarcinoma, endocervical |
 |
 |
 |
Adenocarcinoma, Endocervical |
 |
 |
 |
Adenocarcinoma, Endometrial |
 |
 |
 |
Adenocarcinoma, endometrial |
 |
 |
 |
Adenocarcinoma, endometrial |
 |
 |
 |
Other Malignant Neoplasms: Metastatic gastric carcinoma |
 |
 |
 |
Adenocarcinoma, extrauterine (metastatic from colonic primary) |
 |
 |
 |
LSIL |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended. |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended. |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended. |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note). Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended. |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended. |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended. |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells correlate with the menstrual history provided. |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
Endometrial cells are present in a woman >= 40 years of age.
Negative for squamous intraepithelial lesion. (See Note) Note: Endometrial cells after age 40, particularly out of phase or after menopause may be associated with benign endometrium, hormonal alterations and less commonly, endometrial /uterine abnormalities. Clinical correlation is recommended |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
NILM: Repair |
| |
 |
Not Available |
NILM: Atrophy |
| |
 |
Not Available |
ASC-H |
| |
 |
Not Available |
NILM: Histiocytes |
| |
 |
Not Available |
NILM vs ASC-H |
| |
 |
Not Available |
HSIL extending into gland space |
| |
 |
Not Available |
Squamous cell carcinoma, non-keratinizing |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ (AIS) |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ |
| |
 |
Not Available |
Adenocarcinoma, villoglandular |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ (AIS) /HSIL |
| |
 |
Not Available |
NILM: Negative for intraepithelial lesion or malignancy |
| |
 |
Not Available |
NILM. Atrophy |
| |
 |
Not Available |
Satisfactory: Borderline adequate squamous cellularity |
| |
 |
Not Available |
NILM Endocervical cells |
| |
 |
Not Available |
NILM. Squamous metaplasia |
| |
 |
Not Available |
Unsatisfactory: scant squamous cellularity |
| |
 |
Not Available |
Air Drying Artifact |
| |
 |
Not Available |
Air Drying in HSIL CIN 2 |
| |
 |
Not Available |
Air Drying Artifact |
| |
 |
Not Available |
Squamous cellularity:~1400 cells in this 4X field |
| |
 |
Not Available |
Squamous cellularity~150 cells in this 4X field |
| |
 |
Not Available |
Squamous cellularity~500 cells in this 4X field |
| |
 |
Not Available |
Squamous cellularity:~75 cells in this 4X field |
| |
 |
Not Available |
Squamous cellularity~1000 cells in this 4X field |
| |
 |
Not Available |
Satisfactory Squamous Cellularity |
| |
 |
Not Available |
Satisfactory: Borderline Adequate Squamous Cellularity |
| |
 |
Not Available |
Unsatisfactory due to scant squamous cellularity |
| |
 |
Not Available |
Adenocarcinoma, endocervical |
| |
 |
Not Available |
Adenocarcinoma, extrauterine |
| |
 |
Not Available |
Atypical endocervical cells, favor neoplastic |
| |
 |
Not Available |
Atypical endocervical cells |
| |
 |
Not Available |
Atypical endometrial cells |
| |
 |
Not Available |
Adenocarcinoma, endocervical |
| |
 |
Not Available |
Adenocarcinoma, endocervical |
| |
 |
Not Available |
Atypical endocervical cells, NOS |
| |
 |
Not Available |
Atypical endocervical cells |
| |
 |
Not Available |
Atypical endocervical cells |
| |
 |
Not Available |
Adenocarcinoma, endocervical |
| |
 |
Not Available |
Adenocarcinoma, extrauterine |
| |
 |
Not Available |
Adenocarcinoma, extrauterine (metastatic from colonic primary) |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ (AIS) /HSIL |
| |
 |
Not Available |
ASC-H |
| |
 |
Not Available |
Unsatisfactory |
| |
 |
Not Available |
NILM vs. ASC-H |
| |
 |
Not Available |
NILM vs ASC-US |
| |
 |
Not Available |
NILM: Bacteria morphologically consistent with Actinomyces spp. |
| |
 |
Not Available |
NILM: Atrophy, post-partum |
| |
 |
Not Available |
NILM: Shift in Flora suggestive of bacterial vaginosis |
| |
 |
Not Available |
NILM: Cellular changes consistent with Herpes simplex virus |
| |
 |
Not Available |
NILM: Lymphocytic cervicitis |
| |
 |
Not Available |
NILM: Lymphocytic (follicular) cervicitis |
| |
 |
Not Available |
NILM: Microglandular hyperplasia |
| |
 |
Not Available |
NILM: Microglandular hyperplasia |
| |
 |
Not Available |
NILM: Keratotic cellular changes?"typical parakeratosis" |
| |
 |
Not Available |
NILM: Repair |
| |
 |
Not Available |
NILM: Trichomonas vaginalis and Leptothrix |
| |
 |
Not Available |
NILM: Rectovaginal fistula |
| |
 |
Not Available |
NILM: Fungal organisms consistent with Candida spp |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
HSIL, features suspicious for invasion |
| |
 |
Not Available |
NILM: Rectovaginal fistula |
| |
 |
Not Available |
LSIL |
| |
 |
Not Available |
NILM: Squamous metaplasia |
| |
 |
Not Available |
NILM. Atrophy |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with IUD |
| |
 |
Not Available |
NILM: Atrophy |
| |
 |
Not Available |
NILM: Trichomonas vaginalis |
| |
 |
Not Available |
NILM: Keratotic cellular changes- Hyperkeratosis |
| |
 |
Not Available |
NILM: Repair |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with Radiation |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with IUD |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with IUD |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
ASC-H |
| |
 |
Not Available |
NILM: Trichomonas vaginalis |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ (AIS) |
| |
 |
Not Available |
NILM: Tubal metaplasia |
| |
 |
Not Available |
Adenocarcinoma, extrauterine |
| |
 |
Not Available |
Adenocarcinoma, extrauterine |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
Atypical endocervical cells, favor neoplastic |
| |
 |
Not Available |
Atypical endocervical cells |
| |
 |
Not Available |
Adenocarcinoma, endometrial |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
NILM: Fungal organisms, consistent with Candida spp. |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
ASC-H versus NILM |
| |
 |
Not Available |
NILM vs. ASC-US |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
Squamous cell carcinoma - non keratinizing |
| |
 |
Not Available |
Squamous cell carcinoma |
| |
 |
Not Available |
Atypical endometrial cells |
| |
 |
Not Available |
NILM: Shift in Flora suggestive of bacterial vaginosis |
| |
 |
Not Available |
LSIL |
| |
 |
Not Available |
LSIL |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ (AIS) |
| |
 |
Not Available |
LSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ (AIS) |
| |
 |
Not Available |
Atypical endocervical cells |
| |
 |
Not Available |
NILM: Tubal metaplasia |
| |
 |
Not Available |
Adenocarcinoma, endocervical |
| |
 |
Not Available |
Adenocarcinoma, endometrial |
| |
 |
Not Available |
NILM: Cellular changes consistent with Herpes simplex virus |
| |
 |
Not Available |
NILM: Cellular changes consistent with Herpes simplex virus |
| |
 |
Not Available |
NILM: Reactive squamous metaplasia |
| |
 |
Not Available |
Adenocarcinoma, extrauterine (Breast carcinoma) |
| |
 |
Not Available |
NILM: Fungal organisms, consistent with Candida spp. |
| |
 |
Not Available |
NILM: Endocervical cells |
| |
 |
Not Available |
NILM: Endocervical cells |
| |
 |
Not Available |
ASC-H |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
NILM: Endocervical cells, reactive |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
Atypical glandular cells, favor neoplastic |
| |
 |
Not Available |
Atypical endocervical cells, NOS |
| |
 |
Not Available |
Atypical endocervical cells |
| |
 |
Not Available |
Endocervical adenocarcinoma in situ (AIS) |
| |
 |
Not Available |
Endometrial adenocarcinoma |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
NILM: Endocervical cells |
| |
 |
Not Available |
Unsatisfactory |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
ASC-H |
| |
 |
Not Available |
ASC-H |
| |
 |
Not Available |
Other malignant neoplasms: metastatic transitional cell carcinoma |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
NILM: Reactive Cellular changes associated with IUD |
| |
 |
Not Available |
Adenocarcinoma, Endometrial |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
HSIL with extension into endocervical gland |
| |
 |
Not Available |
HSIL in gland |
| |
 |
Not Available |
HSIL in gland |
| |
 |
Not Available |
HSIL with some features suspicious for invasion |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
endocervical adenocarcinoma in situ, intestinal type (AIS) |
| |
 |
Not Available |
Atypical endometrial cells |
| |
 |
Not Available |
Atypical endometrial cells |
| |
 |
Not Available |
Unsatisfactory- obscuring RBCs and WBCs |
| |
 |
Not Available |
NILM: Lactobacilli |
| |
 |
Not Available |
LSIL/HSIL |
| |
 |
Not Available |
LSIL/HSIL |
| |
 |
Not Available |
LSIL/HSIL |
| |
 |
Not Available |
ASC-US vs LSIL |
| |
 |
Not Available |
LSIL |
| |
 |
Not Available |
LSIL |
| |
 |
Not Available |
NILM: Reactive squamous metaplasia |
| |
 |
Not Available |
NILM: Squamous Metaplasia |
| |
 |
Not Available |
NILM: Reactive endocervical cells |
| |
 |
Not Available |
Small cell undifferentiated carcinoma |
| |
 |
Not Available |
ASC-H vs reactive endocervicals |
| |
 |
Not Available |
NILM: Atrophy |
| |
 |
Not Available |
NILM: Squamous metaplasia |
| |
 |
Not Available |
Satisfactory squamous cellularity. NILM (Atrophy). |
| |
 |
Not Available |
NILM: Trichomonas vaginalis |
| |
 |
Not Available |
Other Malignant Neoplasms: Sarcoma |
| |
 |
Not Available |
Other Malignant Neoplasms: MMMT (carcinosarcoma) |
| |
 |
Not Available |
Other Malignant Neoplasms: Adenoid cystic carcinoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Malignant melanoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Small cell undifferentiated carcinoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Paget disease |
| |
 |
Not Available |
Other Malignant Neoplasms: Malignant melanoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Sarcoma |
| |
 |
Not Available |
Other Malignant Neoplasms: MMMT (carcinosarcoma) |
| |
 |
Not Available |
Other Malignant Neoplasms: Spindle Cell Carcinoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Metastatic small cell undifferentiated carcinoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Paget disease |
| |
 |
Not Available |
Other Malignant Neoplasms: Malignant melanoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Sarcoma |
| |
 |
Not Available |
Other Malignant Neoplasms: MMMT (carcinosarcoma) |
| |
 |
Not Available |
Other Malignant Neoplasms: Spindle Cell Carcinoma |
| |
 |
Not Available |
Other Malignant Neoplasms: Malignant lymphoma |
| |
 |
Not Available |
ASC-H |
| |
 |
Not Available |
NILM: Glandular cells post-hysterectomy (Colonic Neuralgia) |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with Radiation |
| |
 |
Not Available |
NILM: Atrophy with inflammation |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with Radiation |
| |
 |
Not Available |
NILM: Keratotic cellular changes: parakeratosis |
| |
 |
Not Available |
NILM: Reactive squamous cells associated with Trichomonas vaginalis |
| |
 |
Not Available |
NILM: Atrophy |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with Radiation |
| |
 |
Not Available |
NILM: Trichomonas vaginalis and Leptothrix |
| |
 |
Not Available |
NILM: Rectovaginal fistula |
| |
 |
Not Available |
NILM: Syncytiotrophoblast |
| |
 |
Not Available |
NILM : Histiocytes |
| |
 |
Not Available |
NILM: Histiocytes |
| |
 |
Not Available |
NILM: Reactive endocervical cells |
| |
 |
Not Available |
NILM: Tubal metaplasia |
| |
 |
Not Available |
NILM: Endocervical cells: Reactive s/p LEEP |
| |
 |
Not Available |
NILM: Fungal organisms morphologically consistent with Candida spp.(Torulopsis Glabrata) |
| |
 |
Not Available |
NILM: Fungal organisms morphologically consistent with Candida spp.(Torulopsis Glabrata) |
| |
 |
Not Available |
NILM: Glandular cells status post-hysterectomy |
| |
 |
Not Available |
NILM: Reactive endocervical cells |
| |
 |
Not Available |
NILM: Cellular changes consistent with Herpes simplex virus |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with Radiation |
| |
 |
Not Available |
NILM: Reactive endocervical cells |
| |
 |
Not Available |
Unsatisfactory: Obscuring RBCs and WBCs |
| |
 |
Not Available |
NILM: Reactive cellular changes associated with Radiation |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
NILM: Fungal organisms morphologically consistent with Candida spp. |
| |
 |
Not Available |
NILM: Fungal organisms morphologically consistent with Candida spp. |
| |
 |
Not Available |
NILM: Leptothrix and Trichomonas vaginalis |
| |
 |
Not Available |
NILM: Lymphocytic cervicitis |
| |
 |
Not Available |
NILM |
| |
 |
Not Available |
NILM: Repair |
| |
 |
Not Available |
NILM: Tubal metaplasia |
| |
 |
Not Available |
NILM: Histiocytes |
| |
 |
Not Available |
NILM: Fungal organisms morphologically consistent with Candida |
| |
 |
Not Available |
Squamous cell carcinoma |
| |
 |
Not Available |
Squamous cell carcinoma |
| |
 |
Not Available |
Squamous cell carcinoma |
| |
 |
Not Available |
Squamous cell carcinoma |
| |
 |
Not Available |
NILM: Negative for intraepithelial lesion or malignancy |
| |
 |
Not Available |
LSIL |
| |
 |
Not Available |
NILM: Negative for intraepithelial lesion or malignancy |
| |
 |
Not Available |
NILM: Negative for intraepithelial lesion or malignancy |
| |
 |
Not Available |
NILM: Negative for intraepithelial lesion or malignancy |
| |
 |
Not Available |
NILM: Reactive Cellular Changes |
| |
 |
Not Available |
NILM: Fungal organisms morphologically consistent with Candida spp |
| |
 |
Not Available |
ASC-US |
| |
 |
Not Available |
HSIL |
| |
 |
Not Available |
NILM: Cellular changes consistent with Herpes simplex virus |
| |
 |
Not Available |
Other Malignant Neoplasms: Malignant lymphoma, large cell type |